Rheumatology
Conference Coverage
Gout: Studies support early use of urate-lowering therapy, warn of peripheral arterial disease
Urate-lowering drugs might be OK early on; gout may boost peripheral arterial disease.
Latest News
Review estimates acne risk with JAK inhibitor therapy
Acne has been reported to be an adverse effect of JAK inhibitors, but not much is known about how common acne is overall.
Latest News
AI app can do biomechanical analysis in minutes
The motion-capture app could help clinicians design better interventions to ward off mobility problems and speed recovery.
News from the FDA/CDC
FDA OKs first ustekinumab biosimilar
The drug has also been granted an interchangeability designation and has been approved for six indications.
News from the FDA/CDC
FDA approves abatacept for pediatric patients with psoriatic arthritis
As many as 5% of pediatric patients with juvenile idiopathic arthritis are estimated to have juvenile PsA.
From the Journals
RA precision medicine using synovial biopsy ‘remains elusive’
Histologic analysis did not sufficiently predict treatment response to certain medications, but gene expression and transcriptome analysis methods...
From the Journals
Positive trial of methotrexate in hand OA has modest results
A randomized controlled trial of methotrexate in inflammatory hand OA demonstrated clinical benefit, suggesting a potential role for...
Feature
New initiative aims to test investigational OA treatments in high-risk patients after knee injury
A new strategy to test investigational treatments for patients with osteoarthritis (OA) is about to begin in patients who are at risk for...
Conference Coverage
Tricyclics may raise fracture risk in type 2 diabetes
Although the findings are suggestive, they don’t definitively pin blame on tricyclic antidepressants alone in directly leading to fractures.
Feature
Researchers link two genes to Raynaud’s disease
The discovery will hopefully lead to new therapeutic avenues for the condition, experts say.
News from the FDA/CDC
Approximately 20% of U.S. adults are diagnosed with arthritis
New data show disproportionate arthritis prevalence among women, veterans, non-Hispanic White individuals, and those aged 45 years and older.